Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion type Assertion NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_head.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion description "[In both men and women, individuals with variant TS alleles were at reduced risk of having an advanced stage tumor (metastatic disease: OR = 0.35, 95% CI: 0.2-0.6 vs. wildtype TSER and 3'-UTR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_provenance.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion evidence source_evidence_literature NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_provenance.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion SIO_000772 17290389 NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_provenance.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion wasDerivedFrom befree-2016 NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_provenance.
- NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_assertion wasGeneratedBy ECO_0000203 NP593076.RAQc-n2Y2N0TYTChkODL9GMhW4GxFVcwEqqhukr53qL9A130_provenance.